EN
HI
Kabra Drugs Share price
KABRADG
29.99
0.68 (-2.22%)Last updated on 4 Dec, 2025 | 15:28 IST
BUYSELL
Today's High
30.55
Today's Low
29.30
52 Week Low
9.59
52 Week High
32.66
The current prices are delayed, login to your account for live prices
LoginKabra Drugs Chart
Kabra Drugs Share Key Metrics
Volume
1.80 L
Market Cap
72.71 CR
LTQ@LTP
100@29.99
ATP
29.82
Var Margin
100 %
Circuit Range
29.14-32.2
Delivery %
0 %
Value
53.74 L
ASM/GSM
No
Market Lot
1
Kabra Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
36.44
Sector P/B
0.91
Sec. Div. Yield
0.56
Kabra Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2025-11-28 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-10-08 | Others |
| 2025-09-02 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-08-06 | Others |
| 2025-06-18 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-11-04 | Others |
| 2024-08-14 | Quarterly Results |
Kabra Drugs News
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| Mr. N Aravind | Managing Director |
| Mr. Bangalore Venkatakrishnappa Ananth Kumar | WholeTime Director & CFO |
Kabra Drugs Similar Stocks
Unjha Formulations Ltd.
25.20
0.49 (1.98%)
Hindustan Bio Sciences Ltd.
6.04
0.04 (0.67%)
Gian Life Care Ltd.
10.07
-0.53 (5.00%)
Ortin Global Ltd.
13.99
0.66 (4.95%)
Decipher Labs Ltd.
9.67
0.18 (1.90%)
Dhanvantri Jeevan Rekha Ltd.
24.21
0.00 (0.00%)
Dr Lalchandani Labs Ltd.
19.22
-1.01 (4.99%)
Transpact Enterprises Ltd.
165.00
0.00 (0.00%)
MPS Pharmaa Ltd.
0.00
0.00 (0.00%)
Kobo Biotech Ltd.
2.31
-0.12 (4.94%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 29.99 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 36.44 & 0.91 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 72.71 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 32.66 & 9.59. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kabra Drugs belongs to the Healthcare sector.